Home Page What is the ICMA About Us Our faculty PROTECTION® Programme Rationale Programme Overview Protection in High Risk Patients PRISMA I and II SMOOTH ARBs FDC ATHOS PROTECTION® Trials: Renal Protection TRENDY DETAIL INNOVATION AMADEO VIVALDI Conclusion PRoFESS™ Overview Study details Results ONTARGET® Home page Rationale Overview Study Objectives Study Design Endpoints Substudies ONTARGET® results Left Ventricular Hypertrophy results TRANSCEND® results Expert Opinions PRESS CENTRE